J.P. Morgan analyst Ryan Brinkman maintained a Hold rating on Adient on July 10 and set a price target of $26.00. The company’s shares closed last Friday at $19.96.TipRanks Welcomes a New ETF – NYSE:RANK TipRanks has entered a new arena in the investing world, powering the index of an ETF based on its unique data now trading under the ticker RANK on the NYSE. RANK tracks the performance of the TipRanks US Momentum Analysts Index, a rules-based index of 50 large U.S. companies.
According to TipRanks, Brinkman is an analyst with an average return of -0.1% and a 50.71% success rate. Brinkman covers the Consumer Cyclical sector, focusing on stocks such as Visteon, Aptiv, and Lear.
In addition to J.P. Morgan, Adient also received a Hold from Barclays’s Dan Levy in a report issued on July 9. However, on the same day, UBS maintained a Buy rating on Adient (NYSE: ADNT).
Based on Adient’s latest earnings release for the quarter ending March 31, the company reported a quarterly revenue of $3.87 billion and a net profit of $27 million. In comparison, last year the company earned a revenue of $3.61 billion and had a GAAP net loss of $335 million
Based on the recent corporate insider activity of 40 insiders, corporate insider sentiment is negative on the stock. This means that over the past quarter there has been an increase of insiders selling their shares of ADNT in relation to earlier this year. Last month, Heather M Tiltmann, the EVP, CLO, CHRO & Secretary of ADNT sold 22,000.00 shares for a total of $499,620.00.
